Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $1,549,944 |
Sells | 169 | $15,948,143 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
03 Mar 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Mar 2023 | Sale | 5,962 | 22.7071 | 135,380 | D |
08 Feb 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 06 Feb 2023 | Sale | 2,250 | 24.272 | 54,612 | D |
08 Feb 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Feb 2023 | Sale | 1,426 | 25.0201 | 35,679 | D |
08 Feb 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Feb 2023 | Sale | 8,858 | 24.5205 | 217,203 | D |
03 Feb 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Feb 2023 | Sale | 4,495 | 23.0502 | 103,611 | D |
03 Feb 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Feb 2023 | Sale | 10,505 | 22.5213 | 236,586 | D |
09 Jan 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jan 2023 | Sale | 2,250 | 26.402 | 59,404 | D |
09 Jan 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Jan 2023 | Sale | 2,792 | 26.9534 | 75,254 | D |
09 Jan 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Jan 2023 | Sale | 7,492 | 25.6205 | 191,949 | D |
05 Jan 2023 17:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03 Jan 2023 | Sale | 15 | 29.82 | 447 | D |
05 Jan 2023 17:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03 Jan 2023 | Sale | 791 | 28.7759 | 22,762 | D |
05 Jan 2023 17:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03 Jan 2023 | Sale | 2,267 | 27.9028 | 63,256 | D |
05 Jan 2023 17:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03 Jan 2023 | Sale | 11,927 | 26.7973 | 319,611 | D |
14 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 12 Dec 2022 | Sale | 907 | 30.2573 | 27,443 | D |
14 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 12 Dec 2022 | Sale | 1,132 | 28.8266 | 32,632 | D |
14 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 12 Dec 2022 | Sale | 20 | 25.82 | 516 | D |
13 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 12 Dec 2022 | Sale | 10,000 | 30.0428 | 300,428 | D |
13 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 09 Dec 2022 | Sale | 583 | 25.2327 | 14,711 | D |
13 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 09 Dec 2022 | Sale | 3,386 | 24.2335 | 82,055 | D |
12 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 09 Dec 2022 | Sale | 394 | 25.0275 | 9,861 | D |
12 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 08 Dec 2022 | Sale | 3,178 | 24.0821 | 76,533 | D |
12 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 08 Dec 2022 | Sale | 3,199 | 22.5628 | 72,178 | D |
12 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 08 Dec 2022 | Sale | 2,695 | 21.6335 | 58,302 | D |
12 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 08 Dec 2022 | Sale | 928 | 20.9431 | 19,435 | D |
09 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 08 Dec 2022 | Sale | 11,031 | 24.2022 | 266,974 | D |
09 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 08 Dec 2022 | Sale | 20 | 20.58 | 412 | D |
09 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 08 Dec 2022 | Sale | 960 | 20.1185 | 19,314 | D |
09 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 07 Dec 2022 | Sale | 4,558 | 20.4021 | 92,993 | D |
09 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 07 Dec 2022 | Sale | 7,079 | 19.3657 | 137,090 | D |
08 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Dec 2022 | Sale | 615 | 18.2921 | 11,250 | D |
08 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Dec 2022 | Sale | 36,115 | 17.8004 | 642,861 | D |
08 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Dec 2022 | Sale | 1,259 | 16.8984 | 21,275 | D |
08 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Dec 2022 | Sale | 2,011 | 15.6073 | 31,386 | D |
07 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Dec 2022 | Sale | 2,250 | 17.384 | 39,114 | D |
02 Dec 2022 19:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 30 Nov 2022 | Sale | 85 | 19.0604 | 1,620 | D |
02 Dec 2022 19:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Dec 2022 | Sale | 15,000 | 18 | 270,000 | D |
28 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 23 Nov 2022 | Sale | 1,261 | 19.0708 | 24,048 | D |
22 Nov 2022 20:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 22 Nov 2022 | Sale | 174 | 19.0121 | 3,308 | D |
22 Nov 2022 20:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 21 Nov 2022 | Sale | 2 | 19 | 38 | D |
22 Nov 2022 20:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 18 Nov 2022 | Sale | 81 | 20.1335 | 1,631 | D |
22 Nov 2022 20:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 18 Nov 2022 | Sale | 780 | 19.4541 | 15,174 | D |
14 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 11 Nov 2022 | Sale | 121 | 22.1978 | 2,686 | D |
14 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 11 Nov 2022 | Sale | 1,625 | 21.4127 | 34,796 | D |
14 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 11 Nov 2022 | Sale | 4,452 | 20.3851 | 90,754 | D |
14 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 10 Nov 2022 | Sale | 1,800 | 20.0955 | 36,172 | D |
14 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 09 Nov 2022 | Sale | 14,000 | 17.9055 | 250,677 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 07 Nov 2022 | Sale | 215 | 20.293 | 4,363 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 07 Nov 2022 | Sale | 1,430 | 19.823 | 28,347 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 07 Nov 2022 | Sale | 155 | 18.023 | 2,794 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 07 Nov 2022 | Sale | 450 | 17.091 | 7,691 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 08 Nov 2022 | Sale | 8,373 | 18.0888 | 151,458 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Nov 2022 | Sale | 1,660 | 20.2375 | 33,594 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Nov 2022 | Sale | 1,486 | 19.5699 | 29,081 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Nov 2022 | Sale | 3,359 | 18.5768 | 62,399 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Nov 2022 | Sale | 11,122 | 17.7863 | 197,819 | D |
03 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | SENIOR VICE PRESIDENT, CMC | 02 Nov 2022 | Sale | 1,130 | 18.89 | 21,346 | D |
03 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Nov 2022 | Sale | 1,038 | 19.5 | 20,241 | D |
20 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 18 Oct 2022 | Sale | 5,705 | 21.0844 | 120,287 | D |
18 Oct 2022 17:01 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 17 Oct 2022 | Sale | 4,185 | 20.1624 | 84,380 | D |
18 Oct 2022 17:01 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 14 Oct 2022 | Sale | 110 | 20.05 | 2,206 | D |
12 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 10 Oct 2022 | Sale | 1,430 | 17.265 | 24,689 | D |
12 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 10 Oct 2022 | Sale | 3,524 | 16.7401 | 58,992 | D |
11 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Oct 2022 | Sale | 1,757 | 16.4076 | 28,828 | D |
11 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Oct 2022 | Sale | 8,763 | 15.9342 | 139,631 | D |
11 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Oct 2022 | Sale | 948 | 17.3108 | 16,411 | D |
11 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Oct 2022 | Sale | 882 | 16.5404 | 14,589 | D |
11 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Oct 2022 | Sale | 11,210 | 15.6418 | 175,345 | D |
07 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Oct 2022 | Sale | 191 | 16.218 | 3,098 | D |
07 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Oct 2022 | Sale | 2,059 | 15.711 | 32,349 | D |
05 Jul 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03 Jul 2023 | Sale | 10,000 | 18 | 180,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)